Literature DB >> 17028221

Cell-mediated immune responses to smallpox vaccination.

Sung-Han Kim1, Sang-Gu Yeo, Jae-Hyun Cho, Hong-Bin Kim, Nam-Joong Kim, Myoung-don Oh, Kang-Won Choe, Youngmee Jee, Haewol Cho.   

Abstract

We report that vaccine dilution (1:1 or 1:10) and previous vaccinia virus vaccination status had no significant effect on cell-mediated immune responses (i.e., the immediate vaccinia virus-specific gamma interferon-producing T-cell response measured by enzyme-linked immunospot assay) 1 month after smallpox vaccination (Lancy-Vaxina; Berna Biotech, Switzerland).

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 17028221      PMCID： PMC1595313          DOI： 10.1128/CVI.00181-06

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN： 1556-679X


  11 in total

1.  Safety and immunogenicity of new cell-cultured smallpox vaccine compared with calf-lymph derived vaccine: a blind, single-centre, randomised controlled trial.

Authors:  Richard N Greenberg; Jeffrey S Kennedy; David J Clanton; Elizabeth A Plummer; Lynda Hague; John Cruz; Francis A Ennis; William C Blackwelder; Robert J Hopkins
Journal:  Lancet       Date:  2005 Jan 29-Feb 4       Impact factor: 79.321

2.  Clinical responses to smallpox vaccine in vaccinia-naive and previously vaccinated populations: undiluted and diluted Lancy-Vaxina vaccine in a single-blind, randomized, prospective trial.

Authors:  Sung-Han Kim; Sang-Gu Yeo; Hee-Chang Jang; Wan-Beom Park; Chang-Seop Lee; Ki-Deok Lee; Hong-Bin Kim; Nam-Joong Kim; Young-Taek Kim; Youngmee Jee; Haewol Cho; Myoung-don Oh; Kang-Won Choe
Journal:  J Infect Dis       Date:  2005-08-11       Impact factor: 5.226

3.  Cellular immune responses to diluted and undiluted aventis pasteur smallpox vaccine.

Authors:  Michael T Rock; Sandra M Yoder; Thomas R Talbot; Kathryn M Edwards; James E Crowe
Journal:  J Infect Dis       Date:  2006-07-07       Impact factor: 5.226

4.  Clinical and immunological responses to undiluted and diluted smallpox vaccine with vaccinia virus of Lister strain.

Authors:  Szu-Min Hsieh; Shey-Ying Chen; Gwo-Chang Sheu; Min-Nan Hung; Wen-Hsiang Chou; Shan-Chwen Chang; Kwo-Hsiung Hsu
Journal:  Vaccine       Date:  2005-08-18       Impact factor: 3.641

5.  Prediction of residual immunity to smallpox, by means of an intradermal skin test with inactivated vaccinia virus.

Authors:  Sung-Han Kim; Ji-Whan Bang; Kyung-Hwa Park; Wan-Bum Park; Hong-Bin Kim; Nam-Joong Kim; Youngmee Jee; Haewol Cho; Myoung-don Oh; Kang-Won Choe
Journal:  J Infect Dis       Date:  2006-06-30       Impact factor: 5.226

6.  Dose-related effects of smallpox vaccine.

Authors:  Sharon E Frey; Frances K Newman; John Cruz; W Brian Shelton; Janice M Tennant; Tamara Polach; Alan L Rothman; Jeffrey S Kennedy; Mark Wolff; Robert B Belshe; Francis A Ennis
Journal:  N Engl J Med       Date:  2002-03-28       Impact factor: 91.245

7.  Primary induction of human CD8+ cytotoxic T lymphocytes and interferon-gamma-producing T cells after smallpox vaccination.

Authors:  Francis A Ennis; John Cruz; Walter E Demkowicz; Alan L Rothman; David J McClain
Journal:  J Infect Dis       Date:  2002-05-17       Impact factor: 5.226

8.  Evolution of vaccinia virus-specific CD8+ cytotoxic T-lymphocyte responses in primary vaccinees and revaccinees.

Authors:  Allan R Tenorio; Mark E Peeples; Manokiran Patri; Katayoun Rezai; Gordon M Trenholme
Journal:  Clin Diagn Lab Immunol       Date:  2004-07

9.  Clonal vaccinia virus grown in cell culture as a new smallpox vaccine.

Authors:  Richard Weltzin; Jian Liu; Konstantin V Pugachev; Gwendolyn A Myers; Brie Coughlin; Paul S Blum; Richard Nichols; Casey Johnson; John Cruz; Jeffrey S Kennedy; Francis A Ennis; Thomas P Monath
Journal:  Nat Med       Date:  2003-08-17       Impact factor: 53.440

10.  Distinct time effects of vaccination on long-term proliferative and IFN-gamma-producing T cell memory to smallpox in humans.

Authors:  Behazine Combadiere; Alexandre Boissonnas; Guislaine Carcelain; Evelyne Lefranc; Assia Samri; François Bricaire; Patrice Debre; Brigitte Autran
Journal:  J Exp Med       Date:  2004-06-07       Impact factor: 14.307
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.